TrialInternational forum of allergy & rhinology2022

Long-acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study.

Anders Cervin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.